Expression of hemopexin in acute rejection of rat liver allograft identified by serum proteomic analysis

Shock

Volumn 42, Issue 1, 2014, Pages 65-74

  Xu, Min ^a,b   Tan, Changjun ^a   Hu, Jinwu ^a   Alwahsh, Salamah Mohammad ^b   Yan, Jun ^c   Hu, Jie ^a   Dai, Zhi ^a   Wang, Zheng ^a   Zhou, Jian ^a   Fan, Jia ^a   Huang, Xiaowu ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c FUJIAN PROVINCIAL TUMOR HOSPITAL   (China)

Author keywords

acute rejection; HPX; lymphocytes; Rat liver allograft; serum 2D DIGE

Indexed keywords

ALPHA 1 MACROGLOBIN; COMPLEMENT COMPONENT C3; EOSIN; FERRITIN; GAMMA INTERFERON; HEMATOXYLIN; HEME OXYGENASE 1; HEMOPEXIN; INTERLEUKIN 10; INTERLEUKIN 17; KININOGEN; MACROGLOBULIN; MANNOSE BINDING PROTEIN; METALLOTHIONEIN I; PLASMA PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; MESSENGER RNA;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DOWN REGULATION; GRAFT RECIPIENT; IMMUNE RESPONSE; IN VITRO STUDY; LIVER ALLOGRAFT; LIVER GRAFT; LIVER GRAFT REJECTION; LYMPHOCYTE; LYMPHOCYTE CULTURE; MALE; MASS SPECTROMETRY; MIXED LYMPHOCYTE REACTION; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; RAT; SUPERNATANT; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; ACUTE DISEASE; ANIMAL; BIOSYNTHESIS; BLOOD; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECTS; FISCHER 344 RAT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GRAFT REJECTION; IMMUNOLOGY; LEWIS RAT; LIVER; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; METABOLISM; MIXED LYMPHOCYTE CULTURE; PATHOLOGY; PROCEDURES;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GRAFT REJECTION; HEMOPEXIN; LIVER; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MALE; PROTEOMICS; RATS, INBRED F344; RATS, INBRED LEW; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84902537686     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000171     Document Type: Article

References (39)

1. Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, Fisher RA, et al.: Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant 9:301-308, 2009.
2. Klintmalm GB, Washburn WK, Rudich SM, Heffron TG, Teperman LW, Fasola C, Eckhoff DE, et al.: Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study. Liver Transpl 13:1521-1531, 2007.
3. Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, Everhart J, et al.: Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 28:638-645, 1998.
4. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, Fung J, et al.: Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 31:792-799, 2000.
5. Regev A, Molina E, Moura R, Bejarano PA, Khaled A, Ruiz P, Arheart K, et al.: Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl 10: 1233-1239, 2004.
6. Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S: Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant 19:110-114, 2005.
7. Thuluvath PJ, Krok KL: Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am J Gastroenterol 101:1497-1499, 2006.
8. Brent LB: The immunobiology of transplantation. Int Surg 84:275-278, 1999.
9. Hariharan S, Kasiske B, Matas A, Cohen A, Harmon W, Rabb H: Surrogate markers for long-term renal allograft survival. Am J Transplant 4:1179-1183, 2004.
10. ter Meulen CG, Jacobs CW, Wetzels JF, Klasen IS, Hilbrands LB, Hoitsma AJ: The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab. Transplantation 77:281-286, 2004.
11. Hricik DE, Rodriguez V, Riley J, Bryan K, Tary-Lehmann M, Greenspan N, Dejelo C, et al.: Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 3:878-884, 2003.
12. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127:635-648, 2006.
13. Belle A, Tanay A, Bitincka L, Shamir R, O'Shea EK: Quantification of protein half-lives in the budding yeast proteome. Proc Natl Acad Sci U S A 103: 13004-13009, 2006.
14. Yokoyama Y, Terai S, Ishikawa T, Aoyama K, Urata Y, Marumoto Y, Nishina H, et al.: Proteomic analysis of serum marker proteins in recipient mice with liver cirrhosis after bone marrow cell transplantation. Proteomics 6:2564-2570, 2006.
15. Lazzarotto-Silva C, Binato R, Rocher BD, Costa JA, Pizzatti L, Bouzas LF, Abdelhay E: Similar proteomic profiles of human mesenchymal stromal cells from different donors. Cytotherapy 11:268-277, 2009.
16. Wittke S, Haubitz M, Walden M, Rohde F, Schwarz A, Mengel M, Mischak H, et al: Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant 5: 2479-2488, 2005.
17. Schaub S, Wilkins JA, Antonovici M, Krokhin O, Weiler T, Rush D, Nickerson P: Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant 5:729-738, 2005.
18. Kienzl K, Sarg B, Golderer G, Obrist P, Werner ER, Werner-Felmayer G, Lindner H, et al.: Proteomic profiling of acute cardiac allograft rejection. Transplantation 88:553-560, 2009.
19. Nelsestuen GL, Martinez MB, Hertz MI, Savik K, Wendt CH: Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics 5:1705-1713, 2005.
20. Pan TL, Wang PW, Huang CC, Goto S, Chen CL: Expression, by functional proteomics, of spontaneous tolerance in rat orthotopic liver transplantation. Immunology 113:57-64, 2004.
21. Cheng J, Zhou L, Jiang JW, Qin YS, Xie HY, Feng XW, Gao F, et al.: Proteomic analysis of differentially expressed proteins in rat liver allografts developed acute rejection. Eur Surg Res 44:43-51, 2010.
22. Massoud O, Heimbach J, Viker K, Krishnan A, Poterucha J, Sanchez W, Watt K, et al.: Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay. Liver Transpl 17:723-732, 2011.
23. Kamada N, Calne RY: Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 28:47-50, 1979.
24. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25:658-663, 1997.
25. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, Lewis S, Currie I: A novel experimental design for comparative two-dimensional gel analysis: twodimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3:36-44, 2003.
26. Zhang C, Wei J, Zheng Z, Ying N, Sheng D, Hua Y: Proteomic analysis of Deinococcus radiodurans recovering from gamma-irradiation. Proteomics 5: 138-143, 2005.
27. Xu M, Alwahsh SM, Ramadori G, Kollmar O, Slotta JE: Upregulation of hepatic melanocortin 4 receptor during rat liver regeneration. J Surg Res [epub ahead of print] 25 Dec 2013.
28. Immenschuh S, Song DX, Satoh H, Muller-Eberhard U: The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness. Biochem Biophys Res Commun 207:202-208, 1995.
29. Ahmad S, Sultan S, Naz N, Ahmad G, Alwahsh SM, Cameron S, Moriconi F, et al.: Regulation of Iron Uptake in Primary Culture Rat Hepatocytes: The Role of Acute Phase Cytokines. Shock 41:337-345, 2014.
30. Alwahsh SM, Xu M, Seyhan HA, Ahmad S, Mihm S, Ramadori G, Schultze FC: Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver. World J Gastroenterol 20(7):1807-1821, 2014.
31. Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, Moestrup SK: Identification of the receptor scavenging hemopexin-heme complexes. Blood 106:2572-2579, 2005.
32. Brass CA, Immenschuh S, Song DX, Liem HH, Eberhard UM: Hemopexin decreases spontaneous chemiluminescence of cold preserved liver after reperfusion. Biochem Biophys Res Commun 248:574-577, 1998.
33. Baird SK, Kurz T, Brunk UT: Metallothionein protects against oxidative stressinduced lysosomal destabilization. Biochem J 394:275-283, 2006.
34. Geuken E, Buis CI, Visser DS, Blokzijl H, Moshage H, Nemes B, Leuvenink HG, et al.: Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am J Transplant 5:1875-1885, 2005.
35. Spiller F, Costa C, Souto FO, Vinchi F, Mestriner FL, Laure HJ, Alves-Filho JC, et al.: Inhibition of neutrophil migration by hemopexin leads to increased mortality due to sepsis in mice. Am J Respir Crit Care Med 183:922-931, 2011.
36. Smith A, Eskew JD, Borza CM, Pendrak M, Hunt RC: Role of heme-hemopexin in human T-lymphocyte proliferation. Exp Cell Res 232:246-254, 1997.
37. Naz N,Moriconi F, Ahmad S, Amanzada A, Khan S, Mihm S, Ramadori G, et al.: Ferritin L is the sole serum ferritin constituent and a positive hepatic acute-phase protein. Shock 39:520-526, 2013.
38. Rish KR, Swartzlander R, Sadikot TN, Berridge MV, Smith A: Interaction of heme and heme-hemopexin with an extracellular oxidant system used to measure cell growth-associated plasma membrane electron transport. Biochim Biophys Acta 1767:1107-1117, 2007.
39. Fagoonee S, Caorsi C, Giovarelli M, Stoltenberg M, Silengo L, Altruda F, Camussi G, et al.: Lack of plasma protein hemopexin dampens mercuryinduced autoimmune response in mice. J Immunol 181:1937-1947, 2008.